Hypoxia News and Research

RSS
Hypoxia is a condition in which there is a decrease in the oxygen supply to a tissue. In cancer treatment, the level of hypoxia in a tumor may help predict the response of the tumor to the treatment.
FDA approves OrSense's NBM-200MP non-invasive oximetry and low signal oximetry sensor

FDA approves OrSense's NBM-200MP non-invasive oximetry and low signal oximetry sensor

Treating RNA segment in wounds may increase protein levels for growth of skin cells

Treating RNA segment in wounds may increase protein levels for growth of skin cells

Lowering levels of Coonexin46 with use of siRNA will help prevent tumor formation

Lowering levels of Coonexin46 with use of siRNA will help prevent tumor formation

Merck’s MF/F Phase III study data presented at AAAAI annual meeting

Merck’s MF/F Phase III study data presented at AAAAI annual meeting

Fast method for producing bone and cartilage tissue using body's own cells

Fast method for producing bone and cartilage tissue using body's own cells

Journal explores biological and environmental challenges in elite winter sports

Journal explores biological and environmental challenges in elite winter sports

Study of complement reaction can help eliminate reperfusion injuries

Study of complement reaction can help eliminate reperfusion injuries

Sudden infant death syndrome linked to low serotonin levels

Sudden infant death syndrome linked to low serotonin levels

Decreased levels in brainstem of serotonin associated with increased risk for SIDS

Decreased levels in brainstem of serotonin associated with increased risk for SIDS

BMEYE ccNexfin and Masimo Rainbow SET Pulse CO-Oximetry technology receive CE Mark certification

BMEYE ccNexfin and Masimo Rainbow SET Pulse CO-Oximetry technology receive CE Mark certification

BARDA invites Aeolus Pharmaceuticals to submit proposal for development of AEOL 10150

BARDA invites Aeolus Pharmaceuticals to submit proposal for development of AEOL 10150

Aeolus Pharmaceuticals reports financial results for three months and twelve months ended September 30, 2009

Aeolus Pharmaceuticals reports financial results for three months and twelve months ended September 30, 2009

Vion Pharmaceuticals files for bankruptcy

Vion Pharmaceuticals files for bankruptcy

Scientists present new research on adipocyte regulation

Scientists present new research on adipocyte regulation

Researchers develop new method for individually adapted implants

Researchers develop new method for individually adapted implants

Zevalin clinical data presented at 2009 ASH meeting

Zevalin clinical data presented at 2009 ASH meeting

Combination of gene and cell therapy improves critical limb ischemia associated with aging or diabetes

Combination of gene and cell therapy improves critical limb ischemia associated with aging or diabetes

J&JPRD submits an NDA for tapentadol ER tablets

J&JPRD submits an NDA for tapentadol ER tablets

Brain study may yield better treatment for brain injuries associated with stroke and heart attack

Brain study may yield better treatment for brain injuries associated with stroke and heart attack

Study to test anti-tumor effects of AEOL 10150 initiated

Study to test anti-tumor effects of AEOL 10150 initiated